Filing Details
- Accession Number:
- 0001161697-25-000189
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-12 17:00:42
- Reporting Period:
- 2025-06-10
- Filing Date:
- 2025-06-12
- Accepted Time:
- 2025-06-12 17:00:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1872422 | Preethi Sundaram | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Chief Strategy Officer | No | Yes | No | No |
Transaction Summary
| Sold: | 3,924 shares | Avg. Price: $26.41 | Total Value: $103,648.84 |
| Number of Shares After Transactions: | 41,081 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2025-06-10 | 2,324 | $26.41 | 42,681 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2025-06-11 | 1,600 | $26.42 | 41,081 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.49 per share.
- Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.48 per share.
Billionaire Hedge Funds
